Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06974175
NA

Effect of Graminex on Infertility Related to Male Accessory Glands Inflammation

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

View on ClinicalTrials.gov

Summary

Male Accessory Glands Inflammations (MAGI) include inflammatory diseases involving seminal vescicles and the prostate. Patients suffering from them present an impaired fertility because of seminal duct obstruction and alterations of the rheologic and functional parameters of semen, induced by direct microbiological action as well as inflammatory and oxidative damage. Inflammation in seminal plasma can be detected and measured by dosing of inflammatory molecules such as SuPAR and ST2. Treatment of MAGIs include specific antibiotic therapy in addition to use of anti-inflammatory nutraceutics. Deprox HP is a nutraceutic containing GraminexTM, a compound made of pollen extracts of rye, mais and timothy. To investigate its efficacy, we evalued seminal parameters, inflammatory and oxidative molecules in seminal plasma and clinical and ultrasonographic features of male accessory glands before and after 3 months of treatment in 20 patients taking Deprox HP and 20 patients undergoing treatment with palmitoilethanolammide, bromelin and horse chestnut extract.

Official title: Effect of Graminex on Infertility Related to Male Accessory Glands Inflammation. Pilot Study

Key Details

Gender

MALE

Age Range

20 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2025-09-01

Completion Date

2026-05-01

Last Updated

2025-08-14

Healthy Volunteers

No

Interventions

OTHER

Deprox_HP

Use of nutraceutic based on a compound of pollen extracts from pollen, mais and timothy

OTHER

Peacist

Use of a nutraceutic based on palmitoilethanolamide + Bromelin + Horse Chestunt extract

Locations (1)

Fondazione Policlinico Universitario A. Gemelli IRCCS

Roma, Italy